Pathway enrichment analyses of BD risk genes have revealed several significant gene sets, including those that regulate insulin secretion, energy metabolism [6, 7], and corticotropin-releasing hormone (CRH) signaling [14]. This evidence concerns the gene CRH and Behcet disease.